Naturally occurring T cell mutations enhance engineered T cell therapies
Julie Garcia(nLIGHT (United States)), Jaehyuk Choi(Northwestern University)
Cited by 86
Related Papers
Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC)
|Journal for ImmunoTherapy of Cancer|2018|468
Genomic landscape of cutaneous T cell lymphoma
|Nature Genetics|2015|418
Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomas
|Nature Communications|2020|100
Primary cytotoxic T-cell lymphomas harbor recurrent targetable alterations in the JAK-STAT pathway
|Blood|2021|30
Genetic Risk Factors for Early-Onset Merkel Cell Carcinoma
|JAMA Dermatology|2024|14